1.
Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis
by Palmer, Suetonia C, PhD
The Lancet (British edition), 2015, Vol.385 (9982), p.2047-2056
2.
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
by Fox, Caroline S, MD
The Lancet (British edition), 2012, Vol.380 (9854), p.1662-1673
3.
Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
by Welsh, Paul
Diabetologia, 2018, Vol.61 (7), p.1581-1591
4.
Matrix Gla protein T-138C polymorphism is associated with carotid intima media thickness and predicts mortality in patients with diabetic nephropathy
by Roumeliotis, Stefanos
Journal of diabetes and its complications, 2017, Vol.31 (10), p.1527-1532
5.
Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study
by Imai, E
Diabetologia, 2011, Vol.54 (12), p.2978-2986
6.
7.
Regression of albuminuria and its association with incident cardiovascular outcomes and mortality in type 1 diabetes: the FinnDiane Study
by Jansson, Fanny J
Diabetologia, 2018, Vol.61 (5), p.1203-1211
8.
Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes
by Hadjadj, Samy
Diabetologia, 2015, Vol.59 (1), p.208-216
9.
Orthostatic hypotension in diabetic patients—10-year follow-up study
by Gaspar, Ludovit
Journal of diabetes and its complications, 2016, Vol.30 (1), p.67-71
10.
Dietary Sodium Intake and Incidence of Diabetes Complications in Japanese Patients with Type 2 Diabetes: Analysis of the Japan Diabetes Complications Study (JDCS)
by Horikawa, Chika
The journal of clinical endocrinology and metabolism, 2014, Vol.99 (10), p.3635-3643
11.
Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus
by Fufaa, Gudeta D
Diabetologia, 2014, Vol.58 (1), p.188-198
12.
Chronic kidney disease categories and renal–cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25)
by Yokoyama, H
Diabetologia, 2012, Vol.55 (7), p.1911-1918
13.
Effect of duration and burden of microvascular complications on mortality rate in type 1 diabetes: an observational clinical cohort study
by Bjerg, Lasse
Diabetologia, 2019, Vol.62 (4), p.633-643
14.
Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 di...
by von Scholten, Bernt Johan
Journal of diabetes and its complications, 2016, Vol.30 (2), p.248-255
15.
Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease
by Fragoso, André
Journal of diabetes and its complications, 2015, Vol.29 (8), p.1098-1104
16.
Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linköping Diabetes Complications Study
by NORDWALL, M
Diabetologia, 2004, Vol.47 (7), p.1266-1272
17.
Data-driven metabolic subtypes predict future adverse events in individuals with type 1 diabetes
by Lithovius, Raija
Diabetologia, 2017, Vol.60 (7), p.1234-1243
18.
IGFBP-4 Fragments as Markers of Cardiovascular Mortality in Type 1 Diabetes Patients With and Without Nephropathy
by Hjortebjerg, Rikke
The journal of clinical endocrinology and metabolism, 2015, Vol.100 (8), p.3032-3040
19.
Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy
by Jorsal, A
Diabetologia, 2008, Vol.51 (11), p.2100-2107
20.
Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study
by Nin, J. W. M
Diabetologia, 2012, Vol.55 (9), p.2489-2493
